S. Freitag
Signum Technologies, Pennsylvania, United States
Keywords: contactless vital signs, AI biometric sensor, force health protection, biosurveillance, Hyper-Enabled Operator
ROSIE (Remote Optical Sensing for Instant Evaluation) is a proprietary, self-contained biometric sensor system from Signum Technologies. The integrated kit combines a calibrated optical sensor, thermographic module, and onboard compute in a single enclosure, paired with patented AI/ML algorithms to deliver clinical-grade vital signs at 6 to 8 feet of standoff. No wearables, no contact, no subject cooperation required. ROSIE captures heart rate (MAE 1.41 bpm), respiratory rate (MAE under 1.1 breaths/min), and temperature (MAE 0.44 degrees Fahrenheit) from a passive optical signal. Blood oxygen saturation is in development. The system outputs structured vital-sign data over standard interfaces, feeding electronic health record, remote patient monitoring, and Joint Medical Data Layer endpoints, including BATDOK and successor observation platforms. Validation includes a TSA entry-control pilot, Veterans Health Administration telehealth and remote patient monitoring pilots, MITRE and DHS co-development of the multi-vital screening architecture (U.S. patent issued), deployments have documented a 35 percent reduction in manual vital-sign measurement time. SBIR Phase I is submitted with the Chemical and Biological Defense program (ROSIE-CBR). TRL 7. FDA clearance for clinical use is targeted end of FY26; non-clinical defense use cases are fieldable today.